Provided by Tiger Trade Technology Pte. Ltd.

Natera

395.56
-5.0900-1.27%
Post-market: 397.001.44+0.36%19:30 EDT
Volume:2.82M
Turnover:1.11B
Market Cap:56.65B
PE:-288.12
High:401.09
Open:393.02
Low:383.45
Close:400.65
52wk High:437.41
52wk Low:167.33
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.36
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:31.10
PE(LYR):-259.07

Loading ...

Movement Alert|Natera Rises 3.22% in Regular Trading, Signatera Approved in Japan for Bladder Cancer Companion Diagnostic as Multiple Banks Raise Price Targets

Market Focus
·
Sep 24

Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement

TradingKey
·
Sep 23

Movement Alert|Natera Rises 3.1% in Regular Trading, Signatera Test Approved in Japan as Bladder Cancer Companion Diagnostic

Market Focus
·
Sep 22

Natera’s Signatera Wins Japan PMDA Approval as Companion Diagnostic in Muscle-Invasive Bladder Cancer

Reuters
·
Sep 22

Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

THOMSON REUTERS
·
Sep 22

Natera- Signatera Commercial Launch in Japan Expected in 1H 2027

THOMSON REUTERS
·
Sep 22

Natera Says Lung Cancer MRD Study Links Signatera Results to 3-Year Recurrence-Free Survival in 1,129 Patients

Reuters
·
Sep 18

Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled

TradingKey
·
Sep 18

Movement Alert|Natera Rises 3.18% in Regular Trading, Multiple Investment Banks Significantly Raise Price Targets

Market Focus
·
Sep 17

Natera Executive Chairman Matthew Rabinowitz Disposes of 89,100 Common Shares Worth $30.15 Million

Reuters
·
Sep 17

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares

Reuters
·
Sep 12

UBS Adjusts Price Target on Natera to $435 From $290, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Natera initiated with a Buy at Rothschild & Co Redburn

TIPRANKS
·
Sep 08

Natera CEO Steven Leonard Chapman Disposes of 1,698 Common Shares for $545,441.02

Reuters
·
Sep 04

Natera announces publication of new data in Blood Neoplasia on Signatera

TIPRANKS
·
Sep 01

CytoDyn Net Loss Widens to $42.7 Million in FY26

Reuters
·
Aug 31

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

THOMSON REUTERS
·
Aug 28

Natera and Angiex partner in tumor testing using Signatera

TIPRANKS
·
Aug 27

Natera Partners with Angiex to Use Signatera ctDNA Test in Agx101 Phase I Trial Monitoring

Reuters
·
Aug 27